Commit and Speech disorder - a phase IV clinical study of FDA data
Summary:
Speech disorder is reported as a side effect among people who take Commit (nicotine polacrilex), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Femara,.
The phase IV clinical study analyzes which people have Speech disorder when taking Commit. It is created by eHealthMe based on reports of 4,836 people who have side effects when taking Commit from the FDA, and is updated regularly.
What is Commit?
Commit has active ingredients of nicotine polacrilex. eHealthMe is studying from 4,842 Commit users. Check the latest studies of Commit.
What is Speech disorder?
Speech disorder is found to be associated with 1,835 drugs and 2,256 conditions by eHealthMe. Check the latest studies of Speech disorder.
4,836 people reported to have side effects when taking Commit.
Among them, 12 people (0.25%) have Speech disorder.

Among these 12 people:
How long have people been on Commit when they have Speech disorder? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Speech disorder when taking Commit? *
- female: 36.36 %
- male: 63.64 %
What is the age of people who have Speech disorder when taking Commit? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 8.33 %
- 30-39: 16.67 %
- 40-49: 8.33 %
- 50-59: 25.0 %
- 60+: 41.67 %
What are other drugs people take besides Commit? *
- Synthroid: 1 person, 8.33%
- Nicoderm Cq: 1 person, 8.33%
- Lipitor: 1 person, 8.33%
- Hydrochlorothiazide: 1 person, 8.33%
- Femara: 1 person, 8.33%
What are other side effects people have besides Speech disorder? *
- Hypersensitivity: 3 people, 25.00%
- Swollen Tongue (swelling of tongue): 2 people, 16.67%
- Dry Mouth: 2 people, 16.67%
- Pharyngolaryngeal Pain: 2 people, 16.67%
- Dyspnea (difficult or laboured breathing): 2 people, 16.67%
- Tongue Blistering: 1 person, 8.33%
- Lip Swelling: 1 person, 8.33%
- Application Site Hyperaesthesia (abnormal increase in sensitivity to stimuli of the sense at application site): 1 person, 8.33%
- Application Site Irritation: 1 person, 8.33%
- Chest Pain: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Commit and have Speech disorder?
- Check whether Speech disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Commit:
- Commit (4,842 reports)
Speech disorder treatments and more:
- Speech disorder (62,574 reports)
How severe was Speech disorder and when was it recovered:
Expand to all the drugs that have ingredients of nicotine polacrilex:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Commit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Speech disorder:
- Speech disorder (1,835 drugs)
Browse all the conditions that are associated with Speech disorder:
- Speech disorder (2,256 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nicotine polacrilex (the active ingredients of Commit) and Commit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cyanocobalamin and Cosentyx drug interactions for women aged 60+ - 2 seconds ago
- Sucralfate and Anxiolytic Therapy for Women aged 20-29 - 9 seconds ago
- Sucralfate and Anxiety And Stress for Women aged 20-29 - 10 seconds ago
- Sucralfate and Tension for Women aged 20-29 - 10 seconds ago
- Sucralfate and Stress for Women aged 20-29 - 10 seconds ago
- Sucralfate and Anxiety, Apprehension, Feeling Uptight, Jitters, Stress, Stress And Anxiety, Tension for Women aged 20-29 - 10 seconds ago
- Sucralfate and Jitters for Women aged 20-29 - 11 seconds ago
- Sucralfate and Feeling Uptight for Women aged 20-29 - 11 seconds ago
- Sucralfate and Apprehension for Women aged 20-29 - 11 seconds ago
- Sucralfate and Anxiety for Women aged 20-29 - 12 seconds ago